Vertex Data Sharpen Focus On Kidney And Pain Revenue Mix

Vertex Pharmaceuticals (NasdaqGS:VRTX) reported positive Phase 3 RAINIER data for povetacicept in IgA nephropathy, meeting ...
Investor's Business Daily on MSN

Vertex pops on 'remarkable' results for chronic kidney disease drug

Vertex stock popped early Tuesday on promising test results for a drug that could treat a chronic autoimmune disease that destroys the kidneys.
Nasdaq

Vertex Announces FDA Approvals of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) and KALYDECO® (ivacaftor) for Use ...

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) expanded the eligibility for ...
BioPharma Dive

Vertex kidney disease drug hits mark in late-stage study

Company shares surged in after-market trading on results for a drug Vertex acquired in a multibillion-dollar deal and sees as ...
WESH

FDA approves new pain drug Journavx as opioid alternative

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...
NBC New York

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

Vertex is now the first drugmaker in decades to gain U.S. approval for a new type of pain medicine. It's a milestone after a long history of mostly unsuccessful efforts to develop painkillers without ...
JD Supra

Vertex’s Attempt to Redefine AKS Falls Short: Key Insights for Pharma Manufacturers

In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of the Inspector General (OIG), manufacturers have ...
FierceBiotech

After reaching FDA first, CRISPR-Vertex's gene editing therapy will get 'benign' review by committee

A historic moment in pharmaceuticals will happen next week: an FDA advisory committee is set to review the first-ever CRISPR gene editing-based therapy, Vertex Pharmaceuticals and CRISPR Therapeutics’ ...
WBUR

FDA approves painkiller designed to eliminate the risk of addiction associated with opioids

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...
NBC Los Angeles

FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades

Stream Los Angeles News for free, 24/7, wherever you are. Vertex is now the first drugmaker in decades to gain U.S. approval for a new type of pain medicine. It's a milestone after a long history of ...